SAN DIEGO, March 12 /PRNewswire-FirstCall/ — Aethlon Medical, Inc. (OTC Bulletin Board: AEMD), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced that Richard H.
See the article here:
Aethlon Medical to Present at The Salk Institute (redOrbit)
Aethlon Medical, Inc. , the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced that Richard H. Tullis, Ph.D., the company’s Chief Science Officer, will present at the French Biotech Tour held at The Salk Institute in La Jolla, California, on March 15, 2010.
See the original post here:
Aethlon Medical to Present at The Salk Institute (PR Newswire via Yahoo! Finance)
Research and Markets (http://www.researchandmarkets.com/research/26a2a4/systemic_fungal_in) has announced the addition of Frost & Sullivan’s new report “Systemic Fungal Infection Therapeutics Market India” to their offering.
Read the rest here:
New report on Systemic Fungal Infection Therapeutics Market India (News-Medical-Net)
Reportlinker.com announces that a new market research report is available in its catalogue:
DUBLIN—-Research and Markets has announced the addition of the “2010 Healthcare Benchmarks: Patient Education and Outreach” report to their offering.
Original post:
Research and Markets: 2010 Healthcare Benchmarks: Patient Education and Outreach (Business Wire via Yahoo! Finance)
We are a country whose citizens do not turn back when confronted by obstacles, whatever they are, and never shrink from lending a helping hand to the most disadvantaged, wherever they may be.
Excerpt from:
Text of the throne speech delieverd Wednesday by Gov. Gen. Michaelle (Brandon Sun)
The U.S. Food and Drug Administration today issued final guidance to help manufacturers who are developing safe and effective cell-based viral vaccines to address emerging and pandemic threats.
Research and Markets has announced the addition of Jain PharmaBiotech’s new report “Antiviral Therapeutics – Technologies, Markets and Companies” to their offering.
See more here:
Report on antiviral approaches for delivery of therapeutics (News-Medical-Net)
Aethlon Medical, Inc. , the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced that Jim Joyce, its Chairman and Chief Executive Officer, will present a corporate update from the NASDAQ Marketsite at the 2010 RedChip New York Equities Conference on March 24, 2010. Â Mr.
POSSIBLE BOXES OR BREAKOUTS—some of which could go online